Medicina
Facultad
University of California Los Angeles
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California Los Angeles (133)
2024
-
Bridging big data in the ENIGMA consortium to combine non-equivalent cognitive measures
Scientific Reports, Vol. 14, Núm. 1
-
Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK)
Critical Care Medicine
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
-
Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))
Genome medicine
-
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
European Urology
-
Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study
Pediatrics, Vol. 153, Núm. 3
-
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine, Vol. 12, Núm. 7, pp. 523-534
-
The Association Between Vasopressin and Adverse Kidney Outcomes in Children and Young Adults Requiring Vasopressors on Continuous Renal Replacement Therapy
Critical Care Explorations, Vol. 6, Núm. 10, pp. e1156
-
Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis
Brain Sciences, Vol. 14, Núm. 7
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis
Molecular Psychiatry, Vol. 28, Núm. 3, pp. 1159-1169
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
-
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095
-
Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study
Journal of Neurotrauma, Vol. 40, Núm. 15-16, pp. 1651-1670
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615
-
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 4, pp. 881-892
2022
-
Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs
Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328
-
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy
British Journal of Clinical Pharmacology, Vol. 88, Núm. 7, pp. 3182-3192